A Chip Stock Gets Checked - Behind the Drop in Intel; and Gilead’s Remdesivir Gets the Green Light
Intel shares plunged after the company reported weak results for its data center group. What’s next for the stock that’s been far underperforming the rest of the semi sector. And Gilead gets FDA approval for remdesivir. We break down the rest of the race for a COVID vaccine.
You May Also Like
Brushwood Media Network
Brushwood Media Network
Prof G Markets
Vox Media Podcast Network
The Prof G Pod with Scott Galloway
The Prof G Pod with Scott
Optimal Work Daily - Career, Productivity and Entrepreneurship
Optimal Living Daily | Dan W.
Handelsblatt Today – Der Finanzpodcast mit News zu Börse, Aktien und Geldanlage
Solveig Gode, Nicole Bastian, Sandra Groeneveld, Nele Dohmen, Anis Mičijević, Ben Mendelson, Aileen Bunte
The Dr. April Jasper Show
Dr. April Jasper
How Money Works
How Money Works
Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT
WELT
Ostan Asuntoja Podcast
Harri Huru
Happy Work - Bien-être au travail et management bienveillant
Gaël Chatelain-Berry
Brushwood Media Network
Brushwood Media Network
Prof G Markets
Vox Media Podcast Network
The Prof G Pod with Scott Galloway
The Prof G Pod with Scott
Optimal Work Daily - Career, Productivity and Entrepreneurship
Optimal Living Daily | Dan W.
Handelsblatt Today – Der Finanzpodcast mit News zu Börse, Aktien und Geldanlage
Solveig Gode, Nicole Bastian, Sandra Groeneveld, Nele Dohmen, Anis Mičijević, Ben Mendelson, Aileen Bunte
The Dr. April Jasper Show
Dr. April Jasper
How Money Works
How Money Works
Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT
WELT
Ostan Asuntoja Podcast
Harri Huru
Happy Work - Bien-être au travail et management bienveillant
Gaël Chatelain-Berry
Community discussion